Highlights Nyrada Inc.

Equities

NYR

AU0000070195

Market Closed - Australian S.E. Other stock markets 01:50:53 2024-05-31 am EDT			5-day change	1st Jan Change
0.057 ^AUD	-1.72%		-8.06%	+159.09%

Apr. 30	Nyrada's NYR-BI03 Being Studied For Potential in Traumatic Brain Injury	MT
Apr. 18	Transcript : Nyrada Inc., Q3 2024 Earnings Call, Apr 18, 2024

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nyrada's NYR-BI03 Being Studied For Potential in Traumatic Brain Injury	Apr. 29	MT
Nyrada Begins Animal Testing on NYR-BI03 Brain Injury Program	Apr. 09	MT
Nyrada Begins Good Laboratory Practice Preclinical Study for Brain Injury Drug Candidate	Mar. 27	MT
Nyrada Inc. Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 20	CI
Nyrada Secures AU$3.5 Million R&D Tax Rebate for Fiscal Year 2023; Shares Surge 30%	Dec. 08	MT
Nyrada Inc. Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-27	CI
Nyrada Completes Preclinical Studies on Cholesterol Lowering Medication	23-05-25	MT
Nyrada Inc. Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-23	CI
Nyrada Inc. Announces Collaboration with Walter Reed and UNSW Extended to 2025	23-01-17	CI
Nyrada Inc. Provides Update on the Progress of Its Brain Injury Program	23-01-10	CI
Nyrada Receives $804,600 R&D Tax Refund; Shares fall 11%	22-11-17	MT
Nyrada Inc. Announces Efficacy Study Published in Journal of Lipid Research	22-10-09	CI
Nyrada Inc. Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-29	CI
Nyrada Inc. Provides Cholesterol-Lowering Program Update	22-06-28	CI
Nyrada Inc. Unveils Target of Its Brain Injury Program as TRPC Ion Channels & Provides Phase I Study Update	22-06-05	CI
Nyrada Secures European Patent for Cholesterol Inhibitor Drug; Shares Rally 16%	22-05-17	MT
European Patent to be Granted for Cholesterol-Lowering Drug of Nyrada Inc	22-05-16	CI
Nyrada Inc. Announces Its Newest Brain Injury Drug Candidate	22-03-28	CI
Nyrada Inc. Reports Earnings Results for the Half Year Ended December 31, 2021	22-02-24	CI
Nyrada Receives $940,000 R&D Tax Refund; Shares Up 4%	22-01-11	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Nyrada Inc.

Equities

NYR

AU0000070195

Highlights

Filters